Drug Patent Expirations in November 2010

Drug Patent Expirations in November 2010

*Drugs may be covered by multiple patents

TradenameApplicantGeneric NamePatent Number Patent Expiration
SAMSCAOtsuka America Pharmtolvaptan5,258,510Nov 2, 2010
TRUVADAGileademtricitabine; tenofovir disoproxil fumarate5,210,085*PEDNov 11, 2010
COZAARMercklosartan potassium5,210,079*PEDNov 11, 2010
EMTRIVAGileademtricitabine5,210,085*PEDNov 11, 2010
ATRIPLAGileadefavirenz; emtricitabine; tenofovir disoproxil fumarate5,210,085*PEDNov 11, 2010
TAXOTERESanofi Aventis Usdocetaxel4,814,470*PEDNov 14, 2010
GEMZARLillygemcitabine hydrochloride4,808,614*PEDNov 15, 2010
RAPAMUNEWyeth Pharms Incsirolimus5,212,155*PEDNov 18, 2010
FORTOVASEHoffmann La Rochesaquinavir5,196,438Nov 19, 2010
INVIRASEHoffmann La Rochesaquinavir mesylate5,196,438Nov 19, 2010
INVIRASERochesaquinavir mesylate5,196,438Nov 19, 2010
VITRAVENE PRESERVATIVE FREENovartisfomivirsen sodium5,264,423Nov 23, 2010
PEPCID ACMerck Sharp Dohmefamotidine5,075,114*PEDNov 23, 2010
PEPCID COMPLETEMerck Sharp Dohmecalcium carbonate; famotidine; magnesium hydroxide5,075,114*PEDNov 23, 2010
ADALAT CCBayer Hlthcarenifedipine5,264,446Nov 23, 2010
PROCARDIA XLPfizernifedipine5,264,446Nov 23, 2010
ARICEPT ODTEisai Incdonepezil hydrochloride4,895,841Nov 25, 2010
ARICEPTEisai Incdonepezil hydrochloride4,895,841Nov 25, 2010
HYCAMTINSmithkline Beechamtopotecan hydrochloride5,004,758*PEDNov 28, 2010
BUTRANSPurdue Pharma Lpbuprenorphine5,240,711Nov 28, 2010

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin. Courtesy of DrugPatentWatch.com


Comments are closed.

Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog